Apica Sellers Representative, LLC v. Abbott Laboratories
- Ona Wang
- 1:23-cv-01034
- U.S. District Court · Southern District of New York
- 5
Apica Sellers Representative v. Abbott Laboratories: Magistrate Judge Wang granted Abbott’s protective order, limiting any privilege waiver to communications through July 2, 2014.
Apica Sellers Representative, LLC and Abbott Laboratories, particularly their discovery obligations and Abbott’s proposed disclosure of privileged or work-product-protected communications.
What happened
In Apica Sellers Representative, LLC v. Abbott Laboratories, the parties disputed how far Abbott’s proposed waiver of attorney-client privilege should extend. The dispute concerned communications between Thoratec Corporation, Abbott’s predecessor in the case, and its in-house lawyers during negotiations over an equity purchase agreement.
Abbott proposed limiting the waiver to communications created on or before July 2, 2014, the agreement’s effective date. Apica argued that this would let Abbott disclose only favorable information and proposed extending the waiver through February 7, 2023, when the complaint was filed.
The court granted Abbott’s request for a protective order. Magistrate Judge Ona T. Wang ruled that any waiver resulting from Abbott’s disclosure would cover protected communications from on or before July 2, 2014; if Abbott makes no disclosure, the communications will remain protected. The court also directed the parties to submit a joint update about remaining discovery and proposed deadlines.
The detailed version
- Apica Sellers Representative, LLC v. Abbott Laboratories · No. 1:23-cv-01034
- Ona Wang
- Dec. 4, 2024
Background
The case concerns the negotiation and drafting of Section 2.05(a)(ii) of a July 2, 2014 equity purchase agreement and the meaning of the term “Product Coil.” Abbott asked the court to define the scope of a possible voluntary subject-matter waiver of attorney-client privilege. Abbott proposed producing documents exchanged during the negotiations between its predecessor, Thoratec Corporation, and Thoratec’s in-house lawyers.
A subject-matter waiver can occur when a party discloses some protected communications and thereby waives protection over related communications. Abbott proposed a cutoff date of July 2, 2014, the agreement’s effective date. Apica, the receiving party, argued that this cutoff would permit Abbott to disclose favorable documents selectively. Apica proposed extending the waiver through February 7, 2023, the date the complaint was filed.
Privilege Waiver
The court relied on its analysis of a prior decision involving a limited privilege waiver. That decision treated the agreement’s effective date as the appropriate end date because communications after the agreement was effective generally did not concern its negotiation. The court found Apica’s proposed date drastically overinclusive because it would extend the waiver nearly ten years beyond the agreement’s effective date.
The court also explained that a party’s unilateral, post-contract understanding of an agreement is not probative of the parties’ intent when they negotiated the agreement. The proposed disclosure involved communications between Thoratec and its own in-house counsel, not communications showing how both contracting parties interpreted the agreement in practice before the litigation.
Ruling
The court granted Abbott’s request for a protective order. If Abbott produces documents exchanged between Thoratec and its in-house counsel concerning the negotiation of Section 2.05(a)(ii), Abbott will waive attorney-client privilege and work-product protection for related privileged or protected communications from on or before July 2, 2014. If Abbott does not produce any privileged documents or communications, the protective order will be moot and those materials will remain protected.
Discovery Deadlines
Because the parties postponed depositions of third-party fact witnesses Jon Shear and Robert Edesess while awaiting the privilege ruling, the court directed the parties to meet and confer. The parties must file a joint status letter by December 9, 2024, identifying any remaining discovery and proposing new deadlines for fact discovery and, if necessary, expert discovery.
Read the full 5-page opinion on CourtListener, the free public archive maintained by the Free Law Project.